• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » DeepWell Digital Therapeutics launches to develop video games for treating health issues

DeepWell Digital Therapeutics launches to develop video games for treating health issues

March 15, 2022 By Sean Whooley

DeepWell Digital Therapeutics DTx DeepWell Digital Therapeutics, a video game developer aiming to combine games and health treatments, was unveiled today.

Seattle-based DeepWell aims to create best-in-class gameplay that can simultaneously entertain and deliver, enhance and accelerate treatment for an array of globally pervasive health conditions, according to a news release.

Devolver Digital co-founder Mike Wilson and Nextern founder and former CEO Ryan Douglas came together to create DeepWell, adding a team of game industry and medical experts to collaborate and lead the development of the company’s own games.

The aim for DeepWell is to work with independent creators worldwide to publish titles across every platform and genre and open the company’s research-driven technologies to assist developers in designing and repurposing games to bring out therapeutic value.

“Our medium is often harshly judged for its perceived negative impacts on the mind and body,” Wilson said in the release. “But, the scientists who study video games, as well as the developers that build them at the highest levels,  already know that the opposite is true. DeepWell is bringing entertainment and medical science together to build upon the proven fact that video games can be good for you, and, thanks to global digital distribution, they’re an important tool to make treatment affordable and accessible.”

The company said more than 40 industry-leading creators, game designers, scientists and medical researchers have joined DeepWell in response to the need to expand the availability of digital therapeutics for psychiatric conditions.

DeepWell expects its first range of games to debut in 2023.

“In order to produce games that provide tangible results, we’ve made engaging gameplay DeepWell’s first principle, since without engagement there is no treatment potential for any therapy,” Douglas said. “With our team of world-class developers at the helm, backed up by cutting-edge science and medical professionals, we’re building and repurposing games that look like, feel like, and play like pure entertainment, but that come imbued with potent digital therapeutics that align with our hardwired, neurological reward mechanisms.

“This is a groundbreaking moment that will bring video games and medicine together in a way that neither field has ever truly contemplated before, prioritizing a level of  patient engagement that has eluded most of modern medicine.” 

Filed Under: Business/Financial News, Digital Health, Featured, Health Technology, News Well, Software / IT Tagged With: DeepWell Digital Therapeutics

More recent news

  • Boston Scientific continues to make progress on cyberattack recovery
  • Edwards Lifesciences, Medtronic score CMS win for TAVR
  • Stryker still working through cyberattack after-effects, stock down more than 10% this week
  • Siemens Healthineers completes $44M R&D, manufacturing site expansion
  • Next-gen Apple Watch Ultra 4 includes new health features

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy